Ergoteles’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-11,226
| Closed | -$851K | – | 1288 |
|
|
2021
Q4 | $851K | Sell |
11,226
-41,480
| -79% | -$3.14M | 0.03% | 465 |
|
|
2021
Q3 | $5.9M | Buy |
52,706
+7,399
| +16% | +$828K | 0.22% | 127 |
|
|
2021
Q2 | $7.34M | Sell |
45,307
-80,804
| -64% | -$13.1M | 0.17% | 170 |
|
|
2021
Q1 | $15.4M | Buy |
+126,111
| New | +$15.4M | 0.48% | 59 |
|